Nuclear Medicine or Radiopharmaceuticals Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028
Nuclear Medicine or Radiopharmaceuticals Market was valued at USD 5700 million in 2021 and is expected to reach USD 9520 million by the year 2028, at a CAGR of 7.6%.
Nuclear medicine is the usage of radioactive substances in diagnostic or therapeutic procedures, particularly to treat various forms of cancer. Nuclear medicine employed in diagnosing or imaging process utilizes small amounts of radioactive substances called radiotracers. These radiotracers are generally injected into the bloodstream, inhaled, or swallowed by the patient where they localize to specific organs and emit radiation. The radiotracer moves through the area that is to be examined and radiates energy in the form of gamma rays. These gamma rays are detected by a special camera and a computer that generates images of the inner side of the body. Nuclear medicine imaging provides detailed unique information that is difficult to obtain using other imaging methods and it also has the potential to identify disease in its earliest stages. Moreover, radiopharmaceuticals are also administered as medicinal solutions containing radioisotopes. These radioactive medicines can destroy cancerous cells by emitting radiation when they reach the target cell.
This Nuclear Medicine or Radiopharmaceuticals Market Report includes information on the manufacturer, such as shipping, pricing, revenue, interview records, gross profit, and company distribution, among other things. These details assist consumers to learn more about their rivals. Likewise, the report outlines the significant difficulties that would have an influence market growth. They also give extensive facts about the industry's potential to key stakeholders, allowing them to expand their industries and increase sales in certain industries. The research will assist companies who are already in or want to enter this market in analyzing the many facets of this domain before investing in or growing their industry in the Nuclear Medicine or Radiopharmaceuticals markets.
To learn more about this report, request a free sample copy: https://introspectivemarketresearch.com/request/15924
Key Industry Players in Nuclear Medicine or Radiopharmaceuticals Market:
• Actinium Pharmaceuticals Inc. (US)
• Alliance Medical (UK)
• Avid Bioservices Inc (US)
• Bayer HealthCare Pharmaceuticals (Germany)
• Bracco Diagnostics Inc. (Italy)
• Cardinal Health Inc. (US)
• GE Healthcare (US)
• Ion Beam Applications S.A (Belgium)
• Jubilant Pharma (India)
• Lantheus Medical Imaging Inc. (US)
• Medi-Radiopharma Ltd (Hungary)
• Nordion Inc. (Canada)
• Novartis/Advanced Accelerator Applications (France)
• Positron Corporation (US)
• Radiopharm Theranostics Ltd. (US), and other major players.
Nuclear medicine is majorly used for diagnosing CVD and cancers. The saturation of these markets has prompted a number of companies and stakeholders to focus on expanding the overall applications of radiopharmaceuticals. With the expanding application areas of radiopharmaceuticals, their demand and uptake are expected to increase in the coming years. This indicates an opportunity for players to expand their offerings and market shares by catering to the demand for radiopharmaceuticals in neurological applications.
Thyroid
By Region: • North America (U.S., Canada, Mexico) • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe) • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC) • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA) • South America (Brazil, Argentina, Rest of SA)
Will you have any doubt about this report? Please contact us on: https://introspectivemarketresearch.com/inquiry/15924
Continue…
Nuclear medicines are a group of pharmaceutical drugs that contain radioactive isotopes. They are exclusive medicinal formulations with radioisotopes and are used in major clinical areas for diagnosis or therapy. Over the past few years, radiopharmaceutical therapies have emerged as one of the most efficient techniques in various areas, such as neurology, cardiology, oncology, and others.
Purchase This Report: -
https://introspectivemarketresearch.com/checkout/?user=1&_sid=15924
The objective of the report is to present comprehensive Global Nuclear Medicine/Radiopharmaceuticals Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report.
Related Report: -
https://introspectivemarketresearch.com/reports/nuclear-imaging-devices-market/
https://introspectivemarketresearch.com/reports/chemical-biological-radiological-andnuclear-cbrn-security-market/
We are a global market research company, specialized in using big data and advanced analytics with strategic consulting to help our clients get acclimatize with the future market trends. Our experts at IMR help our clients gain knowledge about the past and present market condition to gain a holistic idea about the future.
We are a technology-driven research company with strategic analysis. We analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. Our core niches are performing regional demand and estimation and forecasting, Manufacturing and Product sourcing strategy, Competitive and Landscape Analysis, Cost Benefits, DemandSupply Analysis, Mergers and Acquisitions.
or More Information, please contact:
Email: sales@introspectivemarketresearch.com US: +1-773-382-1047 INDIA: +91-81800-96367
US Office 3001 S King Drive, Chicago, Illionis- 60616 USA Phone: 1-773-382-1047
Asia Pacific Office
Introspective Market Research, Office No. 101, Saudamini Commercial Complex, Chandani Chowk, Kothrud, Pune India 411038